Skip to main content


Freshfields Advises Alexion, AstraZeneca Rare Disease on Acquisition of LogicBio® Therapeutics

Freshfields is advising Alexion, AstraZeneca Rare Disease on its acquisition of LogicBio® Therapeutics, Inc. (NASDAQ: LOGC), a pioneering genomic medicine company. The proposed acquisition aims to rapidly accelerate Alexion’s growth in genomic medicines through LogicBio’s unique technology, experienced rare disease R&D team and expertise in pre-clinical development. More details about the transaction can be found here.

The Freshfields team is led by NY M&A Partner Sebastian Fain, Counsel Olaf Ehlers and Associates Anthony Paladino and Chinyere Obi. Partner Adam Golden, Principal Associate Philipp Lehmann and Associates Tanny Kang and Joshua Samuel are advising on Life Sciences transactional matters; Partner Lori Goodman and Associate Lina Zhu on executive compensation and employee benefits matters; Partners Justin Stewart-Teitelbaum and Mary Lehner and Counsel Laura Onken on US antitrust matters; Partner Simon Priddis and Senior Associate Jenny Leahy on EU antitrust matters; Partner Aimen Mir and Special Counsel Christine Laciak on foreign investment matters; Partner Robert Scarborough and Senior Associate David Mitchell on tax matters; and Partner Kyle Lakin and Associate Christian Scott Uhlig on finance matters.


About Freshfields Bruckhaus Deringer LLP

Freshfields Bruckhaus Deringer is a global law firm with a long-standing track record of successfully supporting the world's leading national and multinational corporations, financial institutions and governments on groundbreaking and business-critical mandates. Our 2,800-plus lawyers deliver results worldwide through our own offices and alongside leading local firms. Our commitment, local and multinational expertise, and business know-how means our clients rely on us when it matters most.

Freshfields is ranked by Chambers Global in Band 1 across the six areas of antitrust, corporate/M&A, litigation, international arbitration, tax, and public international law. For more information visit

This material is for general information only and is not intended to provide legal advice. Prior results do not guarantee a similar outcome.